Cite
MLA Citation
D Frappaz et al.. “OS4.1 MEVITEM: A European, randomized, open-label, Phase I/II study of vismodegib in combination with temozolomide versus temozolomide alone in adult patients with recurrent or refractory medulloblastoma presenting an activation of the Sonic Hedgehog (SHH) pathway.” Neuro-oncology, vol. 21, n.d., p. iii10. http://access.bl.uk/ark:/81055/vdc_100126059791.0x00000b